Systems Pharmacology for Investigation of the Mechanisms of Action of Traditional Chinese Medicine in Drug Discovery

As a traditional medical intervention in Asia and a complementary and alternative medicine in western countries, traditional Chinese medicine (TCM) has attracted global attention in the life science field. TCM provides extensive natural resources for medicinal compounds, and these resources are generally regarded as effective and safe for use in drug discovery. However, owing to the complexity of compounds and their related multiple targets of TCM, it remains difficult to dissect the mechanisms of action of herbal medicines at a holistic level. To solve the issue, in the review, we proposed a novel approach of systems pharmacology to identify the bioactive compounds, predict their related targets, and illustrate the molecular mechanisms of action of TCM. With a predominant focus on the mechanisms of actions of TCM, we also highlighted the application of the systems pharmacology approach for the prediction of drug combination and dynamic analysis, the synergistic effects of TCMs, formula dissection, and theory analysis. In summary, the systems pharmacology method contributes to understand the complex interactions among biological systems, drugs, and complex diseases from a network perspective. Consequently, systems pharmacology provides a novel approach to promote drug discovery in a precise manner and a systems level, thus facilitating the modernization of TCM.

[1]  Yan Li,et al.  A systematic identification of multiple toxin-target interactions based on chemical, genomic and toxicological data. , 2013, Toxicology.

[2]  Yonghua Wang,et al.  Systems Pharmacology Uncovers the Multiple Mechanisms of Xijiao Dihuang Decoction for the Treatment of Viral Hemorrhagic Fever , 2016, Evidence-based complementary and alternative medicine : eCAM.

[3]  David S. Wishart,et al.  DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..

[4]  A. Hopkins Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[5]  A. Hopkins Network pharmacology , 2007, Nature Biotechnology.

[6]  Yan Li,et al.  Insight into the effects of chiral isomers quinidine and quinine on CYP2D6 inhibition. , 2009, Bioorganic & medicinal chemistry letters.

[7]  Yoshihiro Yamanishi,et al.  Extracting Sets of Chemical Substructures and Protein Domains Governing Drug-Target Interactions , 2011, J. Chem. Inf. Model..

[8]  Zhaolei Zhang,et al.  Alternative signaling pathways: When, where and why? , 2005, FEBS letters.

[9]  J. Lehár,et al.  Synergistic drug combinations improve therapeutic selectivity , 2009, Nature Biotechnology.

[10]  S. Ventegodt,,et al.  Holistic Medicine: Scientific Challenges , 2003, TheScientificWorldJournal.

[11]  T. Baillie,et al.  Organic Chemistry in Drug Discovery , 2004, Science.

[12]  Jing Fan,et al.  Traditional Chinese medicine: potential approaches from modern dynamical complexity theories , 2016, Frontiers of Medicine.

[13]  Dexi Liu,et al.  Cationic transfection lipids. , 2003, Current medicinal chemistry.

[14]  Hao Ye,et al.  HIT: linking herbal active ingredients to targets , 2010, Nucleic Acids Res..

[15]  Xiaomin Luo,et al.  Estimation of elimination half-lives of organic chemicals in humans using gradient boosting machine. , 2016, Biochimica et biophysica acta.

[16]  Xin Wen,et al.  BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..

[17]  A. Wang,et al.  [Evaluation of shensongyangxin capsules in the treatment of paroxysmal atrial fibrillation: a randomized, double-blind and controlled multicenter trial]. , 2011, Zhonghua yi xue za zhi.

[18]  K. Chou,et al.  Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features , 2010, PloS one.

[19]  Xue Xu,et al.  A Systems Biology Approach to Uncovering Pharmacological Synergy in Herbal Medicines with Applications to Cardiovascular Disease , 2012, Evidence-based complementary and alternative medicine : eCAM.

[20]  Yonghua Wang,et al.  Systematic Investigation of Ginkgo Biloba Leaves for Treating Cardio-cerebrovascular Diseases in an Animal Model. , 2017, ACS chemical biology.

[21]  Wei Li,et al.  Investigation of binding features: Effects on the interaction between CYP2A6 and inhibitors , 2010, J. Comput. Chem..

[22]  Peng Jiang,et al.  Molecular networks for the study of TCM Pharmacology , 2010, Briefings Bioinform..

[23]  Konstantin V. Balakin,et al.  Property-Based Design of GPCR-Targeted Library , 2002, J. Chem. Inf. Comput. Sci..

[24]  Ajay N. Jain Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. , 2003, Journal of medicinal chemistry.

[25]  Yonghua Wang,et al.  Deciphering the combination principles of Traditional Chinese Medicine from a systems pharmacology perspective based on Ma-huang Decoction. , 2013, Journal of ethnopharmacology.

[26]  Yonghua Wang,et al.  A Systems-Pharmacology Analysis of Herbal Medicines Used in Health Improvement Treatment: Predicting Potential New Drugs and Targets , 2013, Evidence-based complementary and alternative medicine : eCAM.

[27]  Xiaojie Xu,et al.  CVDHD: a cardiovascular disease herbal database for drug discovery and network pharmacology , 2013, Journal of Cheminformatics.

[28]  Peter J. Park,et al.  Systematic Identification of Synergistic Drug Pairs Targeting HIV , 2012, Nature Biotechnology.

[29]  A. Urtti,et al.  Prediction of the Vitreal Half-Life of Small Molecular Drug-Like Compounds , 2012, Pharmaceutical Research.

[30]  J. Topliss,et al.  QSAR model for drug human oral bioavailability. , 2000, Journal of medicinal chemistry.

[31]  Donald Morrill Of Systems , 2009 .

[32]  Wei Zhang,et al.  ETCM: an encyclopaedia of traditional Chinese medicine , 2018, Nucleic Acids Res..

[33]  Yonghua Wang,et al.  Systematic understanding the mechanisms of vitiligo pathogenesis and its treatment by Qubaibabuqi formula. , 2016, Journal of ethnopharmacology.

[34]  Calvin Yu-Chian Chen,et al.  TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico , 2011, PloS one.

[35]  Yan Li,et al.  A classification study of human β3-adrenergic receptor agonists using BCUT descriptors , 2011, Molecular Diversity.

[36]  Influence of P-glycoprotein on embryotoxicity of the antifouling biocides to sea urchin (Strongylocentrotus intermedius) , 2011, Ecotoxicology.

[37]  Shao Li,et al.  Network Systems Underlying Traditional Chinese Medicine Syndrome and Herb Formula , 2009 .

[38]  Bo Chen,et al.  Sample preparation for analyzing traditional Chinese medicines , 2009 .

[39]  Jianxin Chen,et al.  Large-scale exploration and analysis of drug combinations , 2015, Bioinform..

[40]  Wei Xiao,et al.  Weak-binding molecules are not drugs?—toward a systematic strategy for finding effective weak-binding drugs , 2016, Briefings Bioinform..

[41]  John G. Topliss,et al.  QSAR Model for Drug Human Oral Bioavailability1 , 2000 .

[42]  Yonghua Wang,et al.  Systems Pharmacology Dissecting Holistic Medicine for Treatment of Complex Diseases: An Example Using Cardiocerebrovascular Diseases Treated by TCM , 2015, Evidence-based complementary and alternative medicine : eCAM.

[43]  Lawrence X. Yu An Integrated Model for Determining Causes of Poor Oral Drug Absorption , 1999, Pharmaceutical Research.

[44]  Xue Xu,et al.  A System-Level Investigation into the Mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for Cardiovascular Disease Treatment , 2012, PloS one.

[45]  T. Klabunde Chemogenomic approaches to drug discovery: similar receptors bind similar ligands , 2007, British journal of pharmacology.

[46]  Yuan Wang,et al.  CancerHSP: anticancer herbs database of systems pharmacology , 2015, Scientific Reports.

[47]  Yue Weng,et al.  Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding , 2009, Science.

[48]  Konstantin V. Balakin,et al.  Property-Based Design of GPCR-Targeted Library. , 2003 .

[49]  Jon A Arnot,et al.  Estimating screening-level organic chemical half-lives in humans. , 2014, Environmental science & technology.

[50]  Hua Yu,et al.  A Systematic Prediction of Multiple Drug-Target Interactions from Chemical, Genomic, and Pharmacological Data , 2012, PloS one.

[51]  Xing-Ming Zhao,et al.  Prediction of Drug Combinations by Integrating Molecular and Pharmacological Data , 2011, PLoS Comput. Biol..

[52]  Evi Kostenis,et al.  A physicogenetic method to assign ligand-binding relationships between 7TM receptors. , 2005, Bioorganic & medicinal chemistry letters.

[53]  Liang Sun,et al.  SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping , 2018, Nucleic Acids Res..

[54]  L. Berezhkovskiy Prediction of drug terminal half-life and terminal volume of distribution after intravenous dosing based on drug clearance, steady-state volume of distribution, and physiological parameters of the body. , 2013, Journal of pharmaceutical sciences.

[55]  Wei Zhou,et al.  A novel systems pharmacology model for herbal medicine injection: a case using reduning injection , 2014, BMC Complementary and Alternative Medicine.

[56]  Bin Chen,et al.  PubChem as a Source of Polypharmacology , 2009, J. Chem. Inf. Model..

[57]  Wei Zhou,et al.  A network-based analysis of the types of coronary artery disease from traditional Chinese medicine perspective: potential for therapeutics and drug discovery. , 2014, Journal of ethnopharmacology.

[58]  Roger J. Davis,et al.  TNF and MAP kinase signalling pathways. , 2014, Seminars in immunology.

[59]  Dragos Horvath,et al.  Predicting ADME properties and side effects: the BioPrint approach. , 2003, Current opinion in drug discovery & development.

[60]  David W. Ritchie,et al.  GES Polypharmacology Fingerprints: A Novel Approach for Drug Repositioning , 2014, J. Chem. Inf. Model..

[61]  Wei Zhou,et al.  TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.

[62]  Chao Huang,et al.  Systems pharmacology in drug discovery and therapeutic insight for herbal medicines , 2014, Briefings Bioinform..

[63]  T. Chou Drug combination studies and their synergy quantification using the Chou-Talalay method. , 2010, Cancer research.

[64]  Ling-Yun Wu,et al.  Semi-supervised Drug-Protein Interaction Prediction from Heterogeneous Spaces , 2009 .

[65]  R. Cahn Techniques of extraction , 1996, Nature.

[66]  Gajendra P. S. Raghava,et al.  CancerPPD: a database of anticancer peptides and proteins , 2014, Nucleic Acids Res..

[67]  Yonghua Wang,et al.  A Systems Biology Approach to Understanding the Mechanisms of Action of Chinese Herbs for Treatment of Cardiovascular Disease , 2012, International journal of molecular sciences.

[68]  Li-ping Yang,et al.  Application of systems biology technology in research of traditional Chinese medicine. , 2009, Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan.

[69]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[70]  Tao Xu,et al.  Target Inhibition Networks: Predicting Selective Combinations of Druggable Targets to Block Cancer Survival Pathways , 2013, PLoS Comput. Biol..

[71]  A. Boulesteix PLS Dimension Reduction for Classification with Microarray Data , 2004, Statistical applications in genetics and molecular biology.

[72]  Yan Li,et al.  Systems Pharmacology Dissection of Multiscale Mechanisms of Action for Herbal Medicines in Treating Rheumatoid Arthritis. , 2017, Molecular pharmaceutics.

[73]  Tingjun Hou,et al.  ADME evaluation in drug discovery , 2002, Journal of molecular modeling.

[74]  Y. Z. Chen,et al.  Database of traditional Chinese medicine and its application to studies of mechanism and to prescription validation , 2006, British journal of pharmacology.

[75]  B Agoram,et al.  Predicting the impact of physiological and biochemical processes on oral drug bioavailability. , 2001, Advanced drug delivery reviews.

[76]  B. Roth,et al.  The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches? , 2000 .

[77]  Yoshihiro Yamanishi,et al.  Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework , 2010, Bioinform..

[78]  Yan Li,et al.  Large-scale Direct Targeting for Drug Repositioning and Discovery , 2015, Scientific Reports.

[79]  Lik Tong Tan,et al.  Bioactive natural products from marine cyanobacteria for drug discovery. , 2007, Phytochemistry.

[80]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.

[81]  Esa Alhoniemi,et al.  Clustering of the self-organizing map , 2000, IEEE Trans. Neural Networks Learn. Syst..

[82]  Lin He,et al.  Prediction of Drug-Target Interactions for Drug Repositioning Only Based on Genomic Expression Similarity , 2013, PLoS Comput. Biol..

[83]  Susan E. Abbatiello,et al.  Erratum: Synergistic drug combinations tend to improve therapeutically relevant selectivity , 2009, Nature Biotechnology.

[84]  Hai Pham-The,et al.  Computational modeling of human oral bioavailability: what will be next? , 2018, Expert opinion on drug discovery.

[85]  Rahul Kumar,et al.  CancerDR: Cancer Drug Resistance Database , 2013, Scientific Reports.

[86]  Yonghua Wang,et al.  Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease , 2015, Scientific Reports.

[87]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[88]  Snezana Agatonovic-Kustrin,et al.  Multiple pharmacokinetic parameter prediction for a series of cephalosporins. , 2003, Journal of pharmaceutical sciences.

[89]  Arun Sharma,et al.  Designing of peptides with desired half-life in intestine-like environment , 2014, BMC Bioinformatics.

[90]  Zhenzhong Wang,et al.  Systems Pharmacology Dissection of the Integrated Treatment for Cardiovascular and Gastrointestinal Disorders by Traditional Chinese Medicine , 2016, Scientific Reports.

[91]  J. Ballesteros,et al.  G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin. , 2001, Current opinion in drug discovery & development.

[92]  Xiaojie Xu,et al.  1. Applications of genetic algorithms to the prediction of blood-brain partitioning of a large set of drugs , 2002 .

[93]  Yasubumi Sakakibara,et al.  Statistical prediction of protein-chemical interactions based on chemical structure and mass spectrometry data , 2007, Bioinform..

[94]  Yonghua Wang,et al.  Understanding the Aquatic Toxicity of Pesticide: Structure‐Activity Relationship and Molecular Descriptors to Distinguish the Ratings of Toxicity , 2009 .

[95]  J. Pu,et al.  Chinese Medicine Shensongyangxin Is Effective for Patients with Bradycardia: Results of a Randomized, Double-Blind, Placebo-Controlled Multicenter Trial , 2014, Evidence-based complementary and alternative medicine : eCAM.

[96]  Jing Hu,et al.  Establishing an evaluation mode with multiple primary outcomes based on combination of diseases and symptoms in TCM clinical trials. , 2017, Annals of translational medicine.

[97]  Wen-Jian Wang,et al.  Integration of traditional Chinese medicine and Western medicine in the era of precision medicine. , 2017, Journal of integrative medicine.

[98]  Xiaojie Xu,et al.  Selective separation of active inhibitors of epidermal growth factor receptor from Caragana jubata by molecularly imprinted solid-phase extraction. , 2003, Journal of chromatography. A.

[99]  Zhao Fang,et al.  TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis , 2012, Nucleic Acids Res..

[100]  D. Rognan Chemogenomic approaches to rational drug design , 2007, British journal of pharmacology.

[101]  Thomas M. Ehrman,et al.  Phytochemical Databases of Chinese Herbal Constituents and Bioactive Plant Compounds with Known Target Specificities. , 2007 .

[102]  Yonghua Wang,et al.  Pred-binding: large-scale protein–ligand binding affinity prediction , 2016, Journal of enzyme inhibition and medicinal chemistry.

[103]  F. Cheng,et al.  Systems Pharmacology‐Based Discovery of Natural Products for Precision Oncology Through Targeting Cancer Mutated Genes , 2017, CPT: pharmacometrics & systems pharmacology.

[104]  Qing-Wen Zhang,et al.  Techniques for extraction and isolation of natural products: a comprehensive review , 2018, Chinese Medicine.

[105]  Peng Li,et al.  Insights from systems pharmacology into cardiovascular drug discovery and therapy , 2014, BMC Systems Biology.

[106]  Hua Yu,et al.  A Novel Chemometric Method for the Prediction of Human Oral Bioavailability , 2012, International journal of molecular sciences.

[107]  Charles Boone,et al.  Systems-level antimicrobial drug and drug synergy discovery. , 2013, Nature chemical biology.

[108]  J. Lehár,et al.  Multi-target therapeutics: when the whole is greater than the sum of the parts. , 2007, Drug discovery today.

[109]  G. Johnson,et al.  Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases , 2002, Science.

[110]  Chenchen Wang,et al.  Traditional Chinese Medications for Knee Osteoarthritis Pain: A Meta-Analysis of Randomized Controlled Trials. , 2016, The American journal of Chinese medicine.

[111]  Mingliang Ye,et al.  Biological fingerprinting analysis of traditional Chinese medicines with targeting ADME/Tox property for screening of bioactive compounds by chromatographic and MS methods. , 2007, Mini reviews in medicinal chemistry.

[112]  Dong-Sheng Cao,et al.  Large-scale prediction of drug-target interactions using protein sequences and drug topological structures. , 2012, Analytica chimica acta.

[113]  Jens Sadowski,et al.  Comparison of Support Vector Machine and Artificial Neural Network Systems for Drug/Nondrug Classification , 2003, J. Chem. Inf. Comput. Sci..

[114]  B. Al-Lazikani,et al.  Combinatorial drug therapy for cancer in the post-genomic era , 2012, Nature Biotechnology.

[115]  Aiping Lu,et al.  Syndrome differentiation in modern research of traditional Chinese medicine. , 2012, Journal of ethnopharmacology.

[116]  Oliver Werz,et al.  Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. , 2002, Biochemical pharmacology.

[117]  Jinan Wang,et al.  Systems approaches and polypharmacology for drug discovery from herbal medicines: an example using licorice. , 2013, Journal of ethnopharmacology.

[118]  Xue Xu,et al.  Assessment of toxic interactions of heavy metals in multi-component mixtures using sea urchin embryo-larval bioassay. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[119]  Yuanping Wang,et al.  Chinese herbal medicine for patients with atrial fibrillation: protocol for a systematic review and meta-analysis , 2017, Medicine.

[120]  G Fisch,et al.  Traditional chinese medicine , 2015, Reactions Weekly.

[121]  J. Lehár,et al.  Systematic discovery of multicomponent therapeutics , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[122]  D. Kassel,et al.  Applications of high-throughput ADME in drug discovery. , 2004, Current opinion in chemical biology.